Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value: $783M (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 10,488,076 | $67.86M | 8.7% | $3.07 | — | Common | 452907108 |
| — | TESARO INC | 411,823 | $63.37M | 8.1% | $108.02 | — | Common | 881569107 |
| — | MEDICINES CO | 1,185,000 | $57.95M | 7.4% | $48.90 | — | Common | 584688105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,630,000 | $56.04M | 7.2% | $30.77 | +14.7% | Common | 004225108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 590,000 | $51.79M | 6.6% | $84.70 | +5.0% | Common | 09061G101 |
| — | DERMIRA INC | 1,202,313 | $41.01M | 5.2% | $30.50 | — | Common | 24983L104 |
| FOLD | AMICUS THERAPEUTICS INC | 4,847,577 | $34.56M | 4.4% | $7.50 | -15.7% | Common | 03152W109 |
| — | LION BIOTECHNOLOGIES INC | 4,551,343 | $33.91M | 4.3% | $9.92 | — | Common | 53619R102 |
| — | ARRAY BIOPHARMA INC | 3,780,000 | $33.79M | 4.3% | $8.93 | — | Common | 04269X105 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 815,000 | $30.03M | 3.8% | $16.18 | — | Common | 37890U108 |
| — | TELIGENT INC | 3,791,512 | $29.61M | 3.8% | $7.98 | — | Common | 87960W104 |
| — | SEATTLE GENETICS INC | 450,000 | $28.29M | 3.6% | $56.62 | — | Common | 812578102 |
| — | CLOVIS ONCOLOGY INC | 353,900 | $22.53M | 2.9% | $63.67 | — | Common | 189464100 |
| ASND | ASCENDIS PHARMA | 700,924 | $19.63M | 2.5% | $21.96 | — | Sponsored ADR | 04351P101 |
| — | AERIE PHARMACEUTICALS INC | 425,000 | $19.27M | 2.5% | $37.76 | — | Common | 00771V108 |
| PCRX | PACIRA PHARMACEUTICALS INC | 410,000 | $18.7M | 2.4% | $43.22 | 0.0% | Common | 695127100 |
| — | ASSEMBLY BIOSCIENCES INC | 696,409 | $17.75M | 2.3% | $17.77 | — | Common | 045396108 |
| — | AVEXIS INC | 225,370 | $17.14M | 2.2% | $76.03 | — | Common | 05366U100 |
| — | NEURODERM LTD | 590,000 | $15.66M | 2.0% | $19.87 | — | Common | M74231107 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,603,001 | $13.46M | 1.7% | $4.18 | +66.4% | Common | 09058V103 |
| — | AGENUS INC | 3,368,828 | $12.7M | 1.6% | $4.72 | — | Common | 00847G705 |
| — | MIRATI THERAPEUTICS INC | 2,383,201 | $12.39M | 1.6% | $18.42 | — | Common | 60468T105 |
| VNDA | VANDA PHARMACEUTICALS INC | 617,200 | $8.641M | 1.1% | $12.59 | +13.2% | Common | 921659108 |
| VCYT | VERACYTE INC | 906,999 | $8.326M | 1.1% | $8.92 | -8.3% | Common | 92337F107 |
| — | ALIMERA SCIENCES INC | 5,791,581 | $8.108M | 1.0% | $1.43 | — | Common | 016259103 |
| — | CASCADIAN THERAPEUTICS INC | 1,821,248 | $7.54M | 1.0% | $4.23 | — | Common | 14740B606 |
| CPRX | CATALYST PHARMACEUTICALS INC | 3,804,745 | $7.419M | 0.9% | $1.23 | +3.2% | Common | 14888U101 |
| — | BLUEPRINT MEDICINES CORP | 165,000 | $6.598M | 0.8% | $39.99 | — | Common | 09627Y109 |
| — | AXOVANT SCIENCES LTD | 384,587 | $5.746M | 0.7% | $14.94 | — | Common | G0750W104 |
| — | VIVEVE MEDICAL INC | 890,000 | $5.634M | 0.7% | $6.33 | — | Common | 92852W204 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,192,130 | $4.709M | 0.6% | $8.13 | -38.3% | Common | 83587F202 |
| AKBA | AKEBIA THERAPEUTICS INC | 456,369 | $4.199M | 0.5% | $8.65 | +12.8% | Common | 00972D105 |
| — | FORTRESS BIOTECH INC | 996,663 | $3.688M | 0.5% | $3.13 | — | Common | 34960Q109 |
| CRVS | CORVUS PHARMACEUTICALS INC | 121,715 | $2.528M | 0.3% | $14.40 | +8.8% | Common | 221015100 |
| CLLS | CELLECTIS - ADR | 97,096 | $2.33M | 0.3% | $24.12 | — | Sponsored ADR | 15117K103 |
| — | AVEO PHARMACEUTICALS INC | 3,938,030 | $2.323M | 0.3% | $0.59 | — | Common | 053588109 |
| — | ONCOBIOLOGICS INC | 683,531 | $1.832M | 0.2% | $3.27 | — | Common | 68235M105 |
| — | PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | $1.651M | 0.2% | $0.21 | — | Convertible Debt | 71426VAK4 |
| — | BELLICUM PHARMACEUTICALS INC | 125,000 | $1.543M | 0.2% | $12.34 | — | Common | 079481107 |
| — | TRILLIUM THERAPEUTICS INC | 227,399 | $1.399M | 0.2% | $15.46 | — | Common | 89620X506 |
| — | ARRAY BIOPHARMA INC | 861,400 | $390K | 0.0% | $8.93 | — | Call | 04269X105 |
| — | CLOVIS ONCOLOGY INC | 125,800 | $258K | 0.0% | $63.67 | — | Call | 189464100 |
| FOLD | AMICUS THERAPEUTICS INC | 250,000 | $206K | 0.0% | $7.50 | -15.7% | Call | 03152W109 |
| — | ONCOBIOLOGICS INC - WARRANT A | 233,333 | $187K | 0.0% | $0.46 | — | Warrant | 68235M113 |
| — | ONCOBIOLOGICS INC - WARRANT B | 233,333 | $117K | 0.0% | $0.45 | — | Warrant | 68235M121 |